| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Admission and fasting plasma glucose for estimating risk of death of diabetic and nondiabetic patients with acute coronary syndrome: nonlinearity of hazard ratios and time-dependent comparison
|
Cid-Alvarez, Belen
|
|
2009
|
158 |
6 |
p. 989-997
9 p.
|
artikel
|
| 2 |
Aerobic interval training versus continuous moderate exercise after coronary artery bypass surgery: A randomized study of cardiovascular effects and quality of life
|
Moholdt, Trine T.
|
|
2009
|
158 |
6 |
p. 1031-1037
7 p.
|
artikel
|
| 3 |
Association of platelet responsiveness with clopidogrel metabolism: Role of compliance in the assessment of “resistance”
|
Serebruany, Victor
|
|
2009
|
158 |
6 |
p. 925-932
8 p.
|
artikel
|
| 4 |
Cardiac resynchronization therapy utilization for heart failure: Findings from IMPROVE HF
|
Curtis, Anne B.
|
|
2009
|
158 |
6 |
p. 956-964
9 p.
|
artikel
|
| 5 |
Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: A post hoc analysis of the SPIRIT III randomized trial
|
Hermiller, James B.
|
|
2009
|
158 |
6 |
p. 1005-1010
6 p.
|
artikel
|
| 6 |
Contemporary insights into the functional anatomy of the mitral valve
|
Silbiger, Jeffrey J.
|
|
2009
|
158 |
6 |
p. 887-895
9 p.
|
artikel
|
| 7 |
Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: The Antihypertensive and Lipid Lowering to Prevent Heart Attack Trial (ALLHAT-LLT)
|
Margolis, Karen L.
|
|
2009
|
158 |
6 |
p. 948-955
8 p.
|
artikel
|
| 8 |
Correction
|
|
|
2009
|
158 |
6 |
p. 1045-
1 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2009
|
158 |
6 |
p. A7-
1 p.
|
artikel
|
| 10 |
Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: Results of a double-blind, placebo-controlled, randomized trial
|
Tang, Yi-Da
|
|
2009
|
158 |
6 |
p. 941-947
7 p.
|
artikel
|
| 11 |
Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry
|
Meadows, Telly A.
|
|
2009
|
158 |
6 |
p. 1038-1045
8 p.
|
artikel
|
| 12 |
High incidence of TIMI flow 0 to I in patients with ST-elevation myocardial infarction without electrocardiographic lytic criteria
|
Figueras, Jaume
|
|
2009
|
158 |
6 |
p. 1011-1017
7 p.
|
artikel
|
| 13 |
Impact of computerized dosing on eptifibatide-associated bleeding and mortality
|
Putney, David R.
|
|
2009
|
158 |
6 |
p. 1018-1023
6 p.
|
artikel
|
| 14 |
Information for Readers
|
|
|
2009
|
158 |
6 |
p. A8-
1 p.
|
artikel
|
| 15 |
Long-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery disease
|
Cavender, Matthew A.
|
|
2009
|
158 |
6 |
p. 933-940
8 p.
|
artikel
|
| 16 |
Prognostic importance of a restrictive transmitral filling pattern in patients with symptomatic congestive heart failure and atrial fibrillation
|
Raunsø, Jakob
|
|
2009
|
158 |
6 |
p. 983-988
6 p.
|
artikel
|
| 17 |
Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failure
|
Adams Jr., Kirkwood F.
|
|
2009
|
158 |
6 |
p. 965-971
7 p.
|
artikel
|
| 18 |
Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome
|
Schwartz, Gregory G.
|
|
2009
|
158 |
6 |
p. 896-901.e3
900105 p.
|
artikel
|
| 19 |
Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation
|
Camenzind, Edoardo
|
|
2009
|
158 |
6 |
p. 902-909.e5
9.0899099E7 p.
|
artikel
|
| 20 |
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: The Early Rapid ReversAl of Platelet ThromboSis with Intravenous Elinogrel before PCI to Optimize REperfusion in Acute Myocardial Infarction (ERASE MI) pilot trial
|
Berger, Jeffrey S.
|
|
2009
|
158 |
6 |
p. 998-1004.e1
9043 p.
|
artikel
|
| 21 |
Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: A proposal from the Academic Bleeding Consensus (ABC) Multidisciplinary Working Group
|
Rao, Sunil V.
|
|
2009
|
158 |
6 |
p. 881-886.e1
7980 p.
|
artikel
|
| 22 |
Table of Contents
|
|
|
2009
|
158 |
6 |
p. A3-A6
nvt p.
|
artikel
|
| 23 |
The Balloon pump-assisted Coronary Intervention Study (BCIS-1): Rationale and design
|
Perera, Divaka
|
|
2009
|
158 |
6 |
p. 910-916.e2
90691 p.
|
artikel
|
| 24 |
The clinical significance of hematocrit values before and after percutaneous coronary intervention
|
Maluenda, Gabriel
|
|
2009
|
158 |
6 |
p. 1024-1030
7 p.
|
artikel
|
| 25 |
The impact of kidney transplantation on heart failure risk varies with candidate body mass index
|
Lentine, Krista L.
|
|
2009
|
158 |
6 |
p. 972-982
11 p.
|
artikel
|
| 26 |
Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute coronary syndrome patients: The Canadian Global Registry of Acute Coronary Events (GRACE) experience
|
Banihashemi, Behnam
|
|
2009
|
158 |
6 |
p. 917-924
8 p.
|
artikel
|
Tijdschrift beschrijving